Unknown

Dataset Information

0

Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.


ABSTRACT:

Purpose

Moyamoya syndrome (MMS) is a rare intracranial arterial vasculopathy which can occur in neurofibromatosis type 1 (NF1) disease, representing a cause of cerebrovascular reserve (CVR) impairment, possibly leading to ischemic stroke. Here, we evaluated noninvasive imaging techniques used to assess CVR in MMS patients, describing clinical and imaging findings in patients affected by MMS-NF1.

Methods

Following strict inclusion and exclusion criteria, in this retrospective observational study, we evaluated imaging data of nine consecutive MMS-NF1 patients (M/F?=?5/4, mean age: 12.6?±?4.0). Subjects underwent a multimodal evaluation of cerebral vascular status, including intracranial arterial MR Angiography (MRA), MRI perfusion with dynamic susceptibility contrast (DSC) technique, and 99mTc-hexamethylpropyleneamine oxime (HMPAO) SPECT.

Results

In 8 out 9 patients (88.8%, 6/8 symptomatic), time-to-peak maps were correlated with the involved cerebral hemisphere, while in 6 out 9 patients (66.6%, 5/6 symptomatic), mean transit time (MTT) maps showed correspondence with the affected cerebrovascular territories. Cerebral blood flow (CBF) calculated using DSC perfusion failed to detect the hypoperfused regions instead identified by SPECT-CBF in all patients, while MTT maps overlapped with SPECT-CBF data in all cases and time-to-peak maps in 60.0%.

Conclusions

Although SPECT imaging still represents the gold standard for CBF assessment, our results suggest that data obtained using DSC perfusion technique, and in particular MTT maps, might be a very useful and noninvasive tool for evaluating hemodynamic status in MMS-NF1 patients.

SUBMITTER: D'Amico A 

PROVIDER: S-EPMC7843564 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

D'Amico Alessandra A   Ugga Lorenzo L   Cocozza Sirio S   Giorgio Sara Maria Delle Acque SMDA   Cicala Domenico D   Santoro Claudia C   Melis Daniela D   Cinalli Giuseppe G   Brunetti Arturo A   Pappatà Sabina S  

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20200710 2


<h4>Purpose</h4>Moyamoya syndrome (MMS) is a rare intracranial arterial vasculopathy which can occur in neurofibromatosis type 1 (NF1) disease, representing a cause of cerebrovascular reserve (CVR) impairment, possibly leading to ischemic stroke. Here, we evaluated noninvasive imaging techniques used to assess CVR in MMS patients, describing clinical and imaging findings in patients affected by MMS-NF1.<h4>Methods</h4>Following strict inclusion and exclusion criteria, in this retrospective obser  ...[more]

Similar Datasets

| S-EPMC5453445 | biostudies-literature
| S-EPMC6042724 | biostudies-literature
| S-EPMC4118584 | biostudies-literature
| S-EPMC10047491 | biostudies-literature
| S-EPMC7655282 | biostudies-literature
| S-EPMC9177367 | biostudies-literature
| S-EPMC7781472 | biostudies-literature
| S-EPMC6500903 | biostudies-literature
| S-EPMC7987378 | biostudies-literature
| S-EPMC5453470 | biostudies-literature